VC-backed Cytek Biosciences goes public
Cytek Biosciences, a cell analysis solutions company, has raised $200 million for its IPO after pricing its nearly 7 million shares at $17 per share.
Cytek Biosciences, a cell analysis solutions company, has raised $200 million for its IPO after pricing its nearly 7 million shares at $17 per share.
Copyright PEI Media
Not for publication, email or dissemination